ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nephrology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,116Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 749

$2.95M Total Retail Price of All Prescriptions

Rank: 3 out of 749

508 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

13% of this provider’s 508 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 26,926 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

56% of this provider’s prescriptions were for brand-name drugs, compared to an average of 31%.

Prescription Price

$105 was the average price of a prescription from this provider, compared to $116 among peers.

Prescriptions per Patient

55 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
NEXIUM 1,011 963 1 34
FUROSEMIDE 794 780 2 2
CRESTOR 698 646 3 43
ZOLPIDEM TARTRATE 655 616 4 24
LIDODERM 557 535 5 57
LEVOTHYROXINE SODIUM 543 516 6 13
AMLODIPINE BESYLATE 541 513 7 1
ULORIC 528 509 10 8 72
ALLOPURINOL 503 486 9 10
SIMVASTATIN 483 469 10 5
ATORVASTATIN CALCIUM 473 441 11 18
CLONIDINE HCL 446 423 12 15
TAMSULOSIN HCL 437 434 13 29
DIOVAN 431 408 14 14
JANUVIA 428 419 15 33
TRAMADOL HCL 420 391 16 47
BYSTOLIC 413 399 17 64
DEXILANT 406 401 18 75
DIOVAN HCT 398 398 19 68
METOPROLOL SUCCINATE 386 357 20 26
TRICOR 365 329 21 137
SPIRIVA 314 293 22 138
ZETIA 314 302 22 80
HYDROCODONE-ACETAMINOPHEN 305 288 S3 24 12
ATENOLOL 301 300 25 20
BENICAR 294 294 26 87
BENICAR HCT 285 269 27 141
PLAVIX 284 282 28 56
CELEBREX 269 262 29 54
NAMENDA 262 249 30 60
METOPROLOL TARTRATE 257 240 31 7
POLYETHYLENE GLYCOL 3350 255 255 32 116
LOSARTAN-HYDROCHLOROTHIAZIDE 251 231 33 93
ADVAIR DISKUS 246 228 34 89
OMEPRAZOLE 239 230 35 6
VOLTAREN 228 228 36 105
JANUMET 227 227 37 100
LOVAZA 223 194 38 51
AMIODARONE HCL 219 219 39 113
MECLIZINE HCL 214 213 40 130
RANITIDINE HCL 213 208 41 83
SYNTHROID 209 204 42 82
CLOPIDOGREL 208 202 43 42
GABAPENTIN 205 205 44 25
ISOSORBIDE MONONITRATE ER 192 192 45 45
LIPITOR 170 170 46 71
MELOXICAM 170 158 46 78
METFORMIN HCL 168 168 48 22
TRILIPIX 165 147 49 155
ESCITALOPRAM OXALATE 163 159 50 108
CYMBALTA 163 161 50 127
LYRICA 160 160 52 111
ACIPHEX 160 151 52 156
SINGULAIR 158 145 54 99
VESICARE 156 156 55 134
AVODART 156 156 55 73
DONEPEZIL HCL 153 153 57 55
LISINOPRIL 151 145 58 4
GLIMEPIRIDE 148 148 59 61
ZEMPLAR 147 140 60 63
LACTULOSE 144 144 61 120
RENVELA 143 132 62 3
PANTOPRAZOLE SODIUM 142 137 63 30
ENALAPRIL MALEATE 141 135 64 62
TEKTURNA 136 136 65 117
ALENDRONATE SODIUM 133 123 66 40
CREON 131 131 67 97
PROCRIT 126 125 68 66
PRAVASTATIN SODIUM 124 124 69 49
LOSARTAN POTASSIUM 118 109 70 9
NASONEX 117 108 71 143
LEXAPRO 116 115 72 195
IBANDRONATE SODIUM 114 109 73 218
CARVEDILOL 111 101 74 11
FLECTOR 110 110 75 196
EVISTA 104 104 76 123
ACTONEL 104 104 76 125
LANTUS 100 100 78 36
CAPTOPRIL 96 92 79 210
DOXAZOSIN MESYLATE 96 80 79 38
AZITHROMYCIN 93 93 81 65
HYDRALAZINE HCL 90 83 82 19
COLCRYS 90 90 82 107
SURE COMFORT ALCOHOL 90 90 82 213
HYDROXYZINE HCL 87 85 R 85 145
FINASTERIDE 87 87 85 131
LEVOFLOXACIN 86 84 87 81
LANSOPRAZOLE 86 86 87 207
BENAZEPRIL HCL 81 79 89 23
OLANZAPINE 79 79 90 142
MICARDIS HCT 79 77 90 221
COREG CR 79 79 90 282
FENOFIBRATE 78 76 93 120
SINGLE USE SWAB 78 78 93 200
POTASSIUM CHLORIDE 74 74 95 37
WARFARIN SODIUM 73 73 96 31
SPIRONOLACTONE 72 72 97 44
CLONIDINE 71 71 98 174
ACTOS 71 66 98 70
SUMATRIPTAN SUCCINATE 71 61 98 272
VALSARTAN-HYDROCHLOROTHIAZIDE 69 69 101 288
GLIPIZIDE XL 69 69 101 357
TERAZOSIN HCL 67 67 103 58
VYTORIN 65 65 104 162
AMITIZA 65 65 104 152
BONIVA 65 64 104 231
RANEXA 64 64 107 259
PRADAXA 62 50 108 293
NIFEDIPINE ER 61 58 109 21
NITROSTAT 61 61 109 236
MONTELUKAST SODIUM 61 47 109 181
SPS 60 58 112 198
PREDNISONE 59 50 113 28
PROAIR HFA 58 49 114 98
COUMADIN 57 57 115 313
AVALIDE 57 57 115 381
LUNESTA 56 56 117 243
XARELTO 55 47 118 387
INSULIN SYRINGE 55 55 118 41
HUMALOG 53 52 120 112
BYETTA 52 50 121 289
RAMIPRIL 51 51 122 92
DIGOXIN 50 50 123 95
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 18, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.